22 results
DEF 14C
BGLC
BioNexus Gene Lab Corp
29 Feb 24
Information statement
5:16pm
Committee is charged with the responsibility of reviewing our corporate governance policies and with proposing potential director nominees … management of risks the Company faces, while the Board as a whole has ultimate responsibility for the Company’s oversight of risk management. Our Board
PRE 14C
BGLC
BioNexus Gene Lab Corp
26 Jan 24
Preliminary information
4:05pm
Committee is charged with the responsibility of reviewing our corporate governance policies and with proposing potential director nominees to the Board … the Board as a whole has ultimate responsibility for the Company’s oversight of risk management. Our Board takes an enterprise-wide approach to risk
8-K
EX-3.1
BGLC
BioNexus Gene Lab Corp
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
of authority shall operate to relieve the board or any director from any responsibility imposed by law. The board shall at any time have the power to fill
8-K
EX-1.1
BGLC
BioNexus Gene Lab Corp
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
) no Underwriter has assumed or will assume an advisory or fiduciary responsibility in favor of the Company with respect to any of the transactions
424B4
lbalqef75 imt
21 Jul 23
Prospectus supplement with pricing info
3:37pm
8-K/A
EX-99.1
k0ry0pwtlgpw7i
11 Mar 21
Index to the Audited Financial Statements
3:54pm
10-K
z6gnz4hw kra7rqr7d
31 Mar 20
Annual report
1:12pm
CORRESP
610lb
2 Apr 19
Correspondence with SEC
12:00am
CORRESP
cqnqi
2 Apr 19
Correspondence with SEC
12:00am
S-1/A
8ihb enqvf4a8iqf
25 Feb 19
IPO registration (amended)
3:30pm